Article
Past, Present, and Future Therapeutic Strategies for NF-1-Associated Tumors.
Current oncology reports - 1 Jun 2024
Na Brian, Shah Shilp R, Vasudevan Harish N
Abstract excerpt
PURPOSE OF REVIEW: Neurofibromatosis type 1 (NF-1) is a cancer predisposition syndrome caused by mutations in the NF1 tumor suppressor gene that encodes the neurofibromin protein, which functions as a negative regulator of Ras signaling. We review the past, current, and future state of therapeutic strategies for tumors associated with NF-1. RECENT FINDINGS: Therapeutic efforts for NF-1-associated tumors have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
